Heparin-induced thrombocytopenia differential diagnosis

Revision as of 06:54, 13 July 2017 by Shyam Patel (talk | contribs)
Jump to navigation Jump to search

Heparin-induced thrombocytopenia

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Heparin-induced thrombocytopenia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Heparin-induced thrombocytopenia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Heparin-induced thrombocytopenia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Heparin-induced thrombocytopenia differential diagnosis

CDC on Heparin-induced thrombocytopenia differential diagnosis

Heparin-induced thrombocytopenia differential diagnosis in the news

Blogs on Heparin-induced thrombocytopenia differential diagnosis

Directions to Hospitals Treating Heparin-induced thrombocytopenia

Risk calculators and risk factors for Heparin-induced thrombocytopenia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2] Shyam Patel [3]

Overview

Heparin-induced thrombocytopenia is diagnosed when the platelet count falls by > 50% typically after 5-10 days of heparin therapy. It should be differentiated by other causes of thrombocytopenia like hemolytic uremic syndrome, Thrombotic thrombocytopenia and others.

Differential diagnosis

The table below summarizes the different findings between HIT and other diseases in the differential diagnosis:

Characteristic/Parameter HIT DIC HUS ITP PTP SLE
Symptoms Bleeding, thrombosis, skin necrosis. Bleeding, thrombosis, petechiae, sepsis. Renal failure, hematuria, bleeding, microangiopathic hemolytic anemia. Petechiae, bleeding, other autoimmune diseases. Petechiae, purpura, ecchymoses. Bleeding, photosensitivity, arthritis, malar rash, discoid rash, renal failure, seizures, psychosis.
Platelet count Low but usually more than 20000 per microliter. Low. Low. Low; can be as low as 10000 per microliter. Low; can be less than 10000 per microliter; sudden onset after transfusion. Variable; usually low.
PT and PTT Normal. Elevated. Normal. Normal. Normal. Usually normal.
Etiology Heparin exposure. Sepsis, delivery of fetus, acute promyelocytic leukemia, other malignancy. E.coli strain O157:H7; Shiga-like toxin. Idiopathic; can be secondary to chronic lymphocytic leukemia, HIV, viral hepatitis, H. pylori. Exposure to transfused products. Autoimmunity with development of antibodies to DNA.
Drug-related Yes, always. Possible. No. Yes. No; transfusion-related. Possible; drug-induced lupus can be caused by medications like hydralazine or isoniazid.
Bleeding Possible. Usually. Usually. Yes; spontaneous bleeding if platelet count < 10000 per microliter. Yes; spontaneous bleeding if platelet count < 10000 per microliter. Rare.

Table legend: HIT, heparin-induced thrombocytopenia; DIC, disseminated intravascular coagulation; HUS, hemolytic-uremic syndrome; ITP, immune thrombocytopenia purpura; PTP, post-transfusion purpura; SLE, systemic lupus erythematosis

Reference

Template:WS Template:WH